Center for Drug Evaluation & Research Director Janet Woodcock has a suggestion for the next step in advancing the use of “real world” evidence to support product approvals.
“Can we do a retrospective/prospective experiment?” she asked during March 3-4 workshop on real-world evidence in regulatory decision-making convened by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?